The management of pain is complex having to take into consideration patient specific
characteristics. Drug therapy should be individualized and managed based on numerous …

The long-term therapy of 51 patients using transdermal fentanyl was evaluated. The
transdermal therapy was performed for 158 days (range, 15–855 days). The need for …

Transdermal fentanyl offers the advantage of providing continuous administration of a potent
opioid in the absence of needles and expensive drug-infusion pumps for the treatment of …

BA CKGROUND: Transdermal therapeutic systems offer potential advantages over oral or
intravenous routes of drug administration. The purpose of this prospective study was to …

A multicenter study was conducted to determine the patient and physician acceptability of
transdermal fentanyl in the management of cancer-related pain. In this study, 10 cancer …

Transdermal (TTS) fentanyl therapy has emerged as an effective alternative to the use of
oral opioids for the control of pain in certain cancer patients. These patients are those with …

The transdermal therapeutic system with fentanyl was released in Germany in 1995. Before
and after the release several clinical trials were performed in our pain management unit and …

Transdermal fentanyl patches first became available in the early 1990s and provided an
innovative treatment for the management of cancer pain. Since then, they have become a …

Objective: To determine the safety and efficacy of transdermal fentanyl for pain relief in
cancer patients and to compare the effects on patients according to whether they had …

In this study, 6 patients with pain from advanced cancer were enrolled in a multicenter, open-
label seeding trial of transdermal fentanyl. Following equianalgesic dose conversion …